Katzenohr vs Escalera's Myotis

Clitopilus passeckerianus compared with Myotis escalerai

Key Differences

• Katzenohr is Not Evaluated while Escalera's Myotis is Least Concern.

Taxonomic Classification

Rank	Katzenohr	Escalera's Myotis
Kingdom	Fungi (Pilze)	Animalia (Tier)
Phylum	Basidiomycota (Ständerpilze)	Chordata (Chordatiere)
Class	Agaricomycetes (Mushrooms)	Mammalia (Säugetiere)
Order	Agaricales (Champignonartige)	Chiroptera (Fledertiere)
Family	Entolomataceae	Vespertilionidae
Genus	Clitopilus	Myotis
Species	Clitopilus passeckerianus	Myotis escalerai

Conservation Status

Katzenohr

NE — Not Evaluated

Escalera's Myotis

LC — Least Concern

Physical Characteristics

Attribute	Katzenohr	Escalera's Myotis
Diet	—	—
Average Lifespan	—	—
Average Length	—	—
Average Weight	—	—

Habitat & Geographic Range

Katzenohr

Habitat

Typically found in forest floors, decomposing wood, and soil ecosystems.

Range

Distributed across Norway and Sweden.

Escalera's Myotis

Habitat

Typically found in diverse terrestrial and aquatic ecosystems.

Katzenohr

Clitopilus passeckerianus is a white-rot agaric fungus in the family Entolomataceae notable for its role as a natural producer of pleuromutilin, a diterpenoid antibiotic compound that serves as the biosynthetic precursor for the veterinary and human antibiotic drugs tiamulin and valnemulin, used to treat Mycoplasma infections in livestock. First described from European woodland habitats, the species produces the characteristic Clitopilus fruiting body: a pale, whitish cap with decurrent, crowded gills becoming pinkish at maturity from angular spores, and a farinaceous odor. Its antibiotic-producing capacity makes C. passeckerianus of significant pharmaceutical interest, and biosynthetic studies of pleuromutilin production have informed synthetic chemistry approaches to antibiotic development. The species inhabits temperate deciduous woodland floors in Europe, fruiting in autumn among leaf litter. Discovery of its pleuromutilin biosynthetic pathway has opened avenues for heterologous expression and semi-synthetic modification aimed at developing novel antibiotics to counter antibiotic-resistant bacterial pathogens.